Who owns Puma Biotechnology Inc Common Stock?
- Ticker: PBYI
- CUSIP Number: 74587V107
Tip: Access positions for across all investors
Analyze quarterly positions in Puma Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Puma Biotechnology stock
Who bought or sold Puma Biotechnology Inc Common Stock this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 3.5M | $19M | -8% | Mar 2024 |
|
| Millennium Management | 3.3M | $18M | 4% | Mar 2024 |
|
| Frazier Life Sciences Management | 2.8M | $15M | 100% | Mar 2024 |
|
| Acadian Asset Management | 2.0M | $10M | 5% | Mar 2024 |
|
| BlackRock | 1.6M | $8.6M | 10% | Mar 2024 |
|
| Dr. Jeffrey R. Jay, M.D. | 1.3M | $7.1M | 23% | Mar 2024 |
|
| Athyrium Capital Management | 1.3M | $6.7M | -30% | Mar 2024 |
|
| Susquehanna International | 769k | $4.1M | 274% | Mar 2024 |
|
| Morgan Stanley | 618k | $3.3M | 82% | Mar 2024 |
|
| Dimensional Fund Advisors | 568k | $3.0M | 14% | Mar 2024 |
|
| Geode Capital Management | 453k | $2.4M | 6% | Mar 2024 |
|
| Goldman Sachs Group | 451k | $2.4M | 289% | Mar 2024 |
|
| Jane Street | 429k | $2.3M | 212% | Mar 2024 |
|
| Qube Research & Technologies | 387k | $2.1M | 4537% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 386k | $2.0M | 96% | Mar 2024 |
|
| American Century Companies | 372k | $2.0M | 100% | Mar 2024 |
|
| Sei Investments | 290k | $1.5M | 1% | Mar 2024 |
|
| Two Sigma Advisers | 255k | $1.4M | -10% | Mar 2024 |
|
| Marshall Wace | 239k | $1.3M | -32% | Mar 2024 |
|
| Arrowstreet Capital, Limited Partnership | 230k | $1.2M | 100% | Mar 2024 |
|
| Caption Management | 222k | $1.2M | 100% | Mar 2024 |
|
| Man Group | 212k | $1.1M | 25% | Mar 2024 |
|
| Bank of New York Mellon | 189k | $1.0M | 307% | Mar 2024 |
|
| Winton Capital | 188k | $998k | 100% | Mar 2024 |
|
| GSA Capital Partners | 188k | $994k | -28% | Mar 2024 |
|
| Federated Investors | 162k | $700k | -11% | Dec 2023 |
|
| Prospera Financial Services | 143k | $620k | 17% | Dec 2023 |
|
| Rice Hall James & Associates | 140k | $743k | -58% | Mar 2024 |
|
| Bridgeway Capital Management | 139k | $739k | -6% | Mar 2024 |
|
| Laurion Capital Management | 131k | $695k | 0% | Mar 2024 |
|
| Citigroup | 131k | $692k | -24% | Mar 2024 |
|
| Hrt Financial | 127k | $674k | 100% | Mar 2024 |
|
| Citadel Advisors | 124k | $657k | -18% | Mar 2024 |
|
| Bank Of Montreal | 108k | $605k | 33% | Mar 2024 |
|
| FMR | 92k | $486k | 42% | Mar 2024 |
|
| Cubist Systematic Strategies | 88k | $467k | 149% | Mar 2024 |
|
| Northern Trust | 84k | $443k | 20% | Mar 2024 |
|
| Two Sigma Investments | 82k | $433k | -62% | Mar 2024 |
|
| O'shaughnessy Asset Management | 77k | $409k | 128% | Mar 2024 |
|
| Marathon Trading Investment Management | 70k | $373k | 100% | Mar 2024 |
|
| Assenagon Asset Management | 70k | $372k | -18% | Mar 2024 |
|
| Squarepoint Ops | 61k | $321k | 114% | Mar 2024 |
|
| Jump Financial | 57k | $248k | 132% | Dec 2023 |
|
| XTX Topco | 54k | $287k | 254% | Mar 2024 |
|
| Brevan Howard Capital Management | 50k | $264k | 100% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 47k | $247k | 132% | Mar 2024 |
|
| Metis Global Partners | 40k | $210k | 100% | Mar 2024 |
|
| Point72 Asia | 38k | $203k | 4180% | Mar 2024 |
|
| Comprehensive Portfolio Management | 37k | $198k | 146% | Mar 2024 |
|
| Crestline Management | 35k | $151k | 7% | Dec 2023 |
|
| Balyasny Asset Management | 33k | $173k | -60% | Mar 2024 |
|
| LSV Asset Management | 30k | $161k | -65% | Mar 2024 |
|
| Jpmorgan Chase & Co | 30k | $160k | 11% | Mar 2024 |
|
| LPL Financial | 21k | $110k | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 20k | $103k | 0% | Mar 2024 |
|
| Y-Intercept | 19k | $103k | 100% | Mar 2024 |
|
| Buckingham Strategic Partners | 19k | $102k | 0% | Mar 2024 |
|
| Patriot Financial Group Insurance Agency | 18k | $93k | -70% | Mar 2024 |
|
| Barclays | 17k | $92k | 0% | Mar 2024 |
|
| ExodusPoint Capital Management | 16k | $83k | 100% | Mar 2024 |
|
| Bank of America Corporation | 15k | $81k | -88% | Mar 2024 |
|
| CTC Alternative Strategies | 12k | $64k | 100% | Mar 2024 |
|
| Royce & Associates | 12k | $62k | 100% | Mar 2024 |
|
| LMR Partners | 11k | $58k | 100% | Mar 2024 |
|
| Commonwealth Equity Services | 11k | $57k | 0% | Mar 2024 |
|
| SG Americas Securities | 11k | $57k | 100% | Mar 2024 |
|
| UBS Group | 11k | $56k | -4% | Mar 2024 |
|
| Wells Fargo & Company | 8.3k | $44k | 2574% | Mar 2024 |
|
| State of Wyoming | 6.7k | $35k | 100% | Mar 2024 |
|
| Headlands Technologies | 2.3k | $12k | 100% | Mar 2024 |
|
| Rhumbline Advisers | 2.1k | $11k | 0% | Mar 2024 |
|
| Tower Research Capital | 1.7k | $9.0k | -62% | Mar 2024 |
|
| Group One Trading | 1.5k | $7.9k | 100% | Mar 2024 |
|
| GHP Investment Advisors | 1.2k | $6.2k | 0% | Mar 2024 |
|
| GPS Wealth Strategies Group | 1.0k | $5.3k | 0% | Mar 2024 |
|
| Simplex Trading | 947.00 | $5.0k | -84% | Mar 2024 |
|
| Lazard Asset Management | 946.00 | $4.0k | 100% | Dec 2023 |
|
| Atlantic Trust | 775.00 | $4.1k | 100% | Mar 2024 |
|
| Goss Wealth Management | 717.00 | $3.8k | 100% | Mar 2024 |
|
| Aspire Private Capital | 700.00 | $3.7k | 0% | Mar 2024 |
|
| Advisor Group Holdings | 650.00 | $3.4k | 86% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 242.00 | $1.3k | 0% | Mar 2024 |
|
| Us Bancorp | 200.00 | $1.1k | 0% | Mar 2024 |
|
| Zrc Wealth Management | 3.00 | $15.999900 | 0% | Mar 2024 |
|
Who sold out of Puma Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| 683 Capital Management | Dec 2023 | 55k | $238k |
| Franklin Resources | Dec 2023 | 19k | $83k |
| Royal Bank of Canada | Dec 2023 | 5.1k | $22k |
| Lindbrook Capital | Dec 2023 | 2.8k | $12k |
| JNBA Financial Advisors | Dec 2023 | 4.00 | $18.000000 |